Market revenue in 2023 | USD 249.7 million |
Market revenue in 2030 | USD 573.4 million |
Growth rate | 12.6% (CAGR from 2023 to 2030) |
Largest segment | Disposable equipment |
Fastest growing segment | Disposable Equipment |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Disposable Equipment, Capital Equipment, Reusable Equipment |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Stryker Corp, Abbott Laboratories, Smith & Nephew PLC, Johnson & Johnson, AngioDynamics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiofrequency ablation devices market will help companies and investors design strategic landscapes.
Disposable equipment was the largest segment with a revenue share of 42.77% in 2023. Horizon Databook has segmented the Japan radiofrequency ablation devices market based on disposable equipment, capital equipment, reusable equipment covering the revenue growth of each sub-segment from 2018 to 2030.
Life expectancy in Japan is increasing, while birth rate is low, resulting in the highest geriatric population. According to University of Chicago, in 2014, 26% of the people in Japan were over the age of 65, and this number is expected to increase, reaching 38.8% by 2050.
Therefore, increase in the incidence of sarcoma is proportional to the increasing life expectancy, which raises the need for treatment, boosting market growth. The use radiofrequency ablation method was approved in Japan by the National Health Insurance in April 2004.
Technological advancements have led to development of minimally invasive techniques to substitute conventional surgery, which includes nonsurgical ablations, especially RFA. For example, the use of RFA in the field of Hepatocellular Carcinoma (HCC).
Horizon Databook provides a detailed overview of country-level data and insights on the Japan radiofrequency ablation devices market , including forecasts for subscribers. This country databook contains high-level insights into Japan radiofrequency ablation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account